156 related articles for article (PubMed ID: 4266852)
1. [Dermatological externals, particularly their releasing capacity].
Hagerman G
Z Haut Geschlechtskr; 1973 Feb; 48(3):97-105. PubMed ID: 4266852
[No Abstract] [Full Text] [Related]
2. [Some data on external therapy of dermatoses].
Ormea TF
Minerva Med; 1973 Oct; 64(77):4021-8. PubMed ID: 4764073
[No Abstract] [Full Text] [Related]
3. [Comparative analysis of the efficacy of external application of various corticosteroid preparations in skin diseases].
Zelikov AKh
Vestn Dermatol Venerol; 1970 Feb; 44(2):62-4. PubMed ID: 5469950
[No Abstract] [Full Text] [Related]
4. [New data on the use of dimethylsulfoxide in experimental and clinical dermatology (a survey of the literature)].
Datskovskii BM; Zaks AS; Mitriukovskii LS
Vestn Dermatol Venerol; 1973 Jan; 47(1):30-6. PubMed ID: 4575609
[No Abstract] [Full Text] [Related]
5. [The external treatment of dermatoses (author's transl)].
Ormea F
MMW Munch Med Wochenschr; 1974 Mar; 116(13):637-42. PubMed ID: 4212846
[No Abstract] [Full Text] [Related]
6. A novel foam vehicle for delivery of topical corticosteroids.
Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
[TBL] [Abstract][Full Text] [Related]
7. [A new type of topical corticoid. Principle and experimental activity control].
Escande JP
Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528
[No Abstract] [Full Text] [Related]
8. A guide to topical corticosteroids.
Goldman L
Am Fam Physician; 1973 Sep; 8(3):167-70. PubMed ID: 4729714
[No Abstract] [Full Text] [Related]
9. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
Worthington HE
Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
[No Abstract] [Full Text] [Related]
10. [Basic viewpoints in the modern treatment of eczema].
Schneider W
Hautarzt; 1975 Feb; 26(2):88-91. PubMed ID: 236267
[No Abstract] [Full Text] [Related]
11. Drugs for acne, rosacea and psoriasis.
Treat Guidel Med Lett; 2005 Jul; 3(35):49-56. PubMed ID: 15961971
[No Abstract] [Full Text] [Related]
12. [Vitamin B12 cream--a pharmacologic-galenic evaluation].
Wolf G
Hautarzt; 2009 Dec; 60(12):1010-2. PubMed ID: 19921105
[No Abstract] [Full Text] [Related]
13. [The skin as absorptive organ from the pharmacokinetic viewpoint].
Stüttgen G
Arzneimittelforschung; 1972 Feb; 22(2):324-9. PubMed ID: 5067484
[No Abstract] [Full Text] [Related]
14. [Corticosteroids and their vehicle in the treatment of scalp psoriasis].
Wauters O; Roland I; De la Brassinne M
Rev Med Liege; 2007 Apr; 62(4):196-9. PubMed ID: 17566388
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experiences of interval treatment with dermatologic agents containing urea].
Petres J; Antal I; Füzesi S
Z Hautkr; 1990 Aug; 65(8):740-5. PubMed ID: 2284833
[TBL] [Abstract][Full Text] [Related]
16. [The administration of corticosteroid ointments and creams].
Polano MK
Ned Tijdschr Geneeskd; 1986 Apr; 130(14):624-7. PubMed ID: 3703033
[No Abstract] [Full Text] [Related]
17. [The oral corticosteroid treatment of "benign" dermatoses].
Jadassohn W; Musso E
Munch Med Wochenschr; 1967 Jul; 109(29):1539-41. PubMed ID: 4232480
[No Abstract] [Full Text] [Related]
18. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
Zivkovich AH; Feldman SR
J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
[TBL] [Abstract][Full Text] [Related]
19. [MECHANISM AND NORM OF THE PHYSICAL THERMO-EFFECT OF DERMATOLOGICAL EXTERNAL AGENTS].
KLEINE-NATROP HE
Dermatol Wochenschr; 1963 Jan; 147():81-93. PubMed ID: 14172115
[No Abstract] [Full Text] [Related]
20. Psoriasis: practical therapeutic perspectives.
Van Scott EJ
Ration Drug Ther; 1973 Aug; 7(8):1-5. PubMed ID: 4731081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
